{"name":"Zydus Worldwide DMCC","slug":"zydus-worldwide-dmcc","ticker":"","exchange":"","domain":"","description":"Zydus Worldwide DMCC is a pharmaceutical company focused on developing and commercializing innovative dermatological treatments. The company has a strong pipeline with two drugs in Phase 3 trials, including a placebo for Ivermectin cream and Soolantra® Ivermectin cream 1%. Zydus Worldwide DMCC aims to address unmet needs in dermatology through its research and development efforts.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Placebo for Ivermectin cream 1%","genericName":"Placebo for Ivermectin cream 1%","slug":"placebo-for-ivermectin-cream-1","indication":"Treatment of rosacea","status":"phase_3"},{"name":"Soolantra® Ivermectin cream 1%","genericName":"Soolantra® Ivermectin cream 1%","slug":"soolantra-ivermectin-cream-1","indication":"Rosacea (inflammatory lesions)","status":"phase_3"}]}],"pipeline":[{"name":"Placebo for Ivermectin cream 1%","genericName":"Placebo for Ivermectin cream 1%","slug":"placebo-for-ivermectin-cream-1","phase":"phase_3","mechanism":"This is a placebo, meaning it has no active therapeutic effect.","indications":["Treatment of rosacea"],"catalyst":""},{"name":"Soolantra® Ivermectin cream 1%","genericName":"Soolantra® Ivermectin cream 1%","slug":"soolantra-ivermectin-cream-1","phase":"phase_3","mechanism":"Ivermectin is a macrocyclic lactone that binds to glutamate-gated chloride channels in parasites and may modulate innate immune responses in the skin.","indications":["Rosacea (inflammatory lesions)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPN0lsLTAwUEplalczSlJhb1d5LVVsaFlaaG5kLVRSV29vOF9MQ014MzNseXotelh1d1djTDVlSkQyNmhCRmFDd2VXajhDRGZsSDdENHRLMXBVb2ZBZGtISC1jeHFoRzN1dXBYR2dIVGRqdS1IRWoxUFZ2Rkg4SGFELU9ac1dKNmFhSE1hZkpBVElSQUdjVVFRUWQwc2dRNlVVTk9IVGhB0gGuAUFVX3lxTE1RQnBYS05JUHctV2ctcjBaSU9Nc3dCM1YwT2lzLU9aUVpYbEFSLUFyZ0JMMnl1YXhGVWpfVDRRV3JJR0huTlZ4VGk2eExiVjZ0TUdMTlRqUU90S0F5NGFjS2N6RFFYZTI0YnBQMVpOYzU2TzNzbzRSdzV4MVhaOUFFV1c3Y0lJUzJ0UE1vQXphSGY3aFNxWGs5M05XdlZQWFhKZnAxb3hiZFpwYnZTQQ?oc=5","date":"2025-05-20","type":"earnings","source":"NDTV Profit","summary":"Zydus Lifesciences Q4 Results: Revenue Surges 18%, Profit Down - NDTV Profit","headline":"Zydus Lifesciences Q4 Results: Revenue Surges 18%, Profit Down","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2024-01-19","type":"pipeline","source":"Medical Dialogues","summary":"Zydus, Synthon enter into licensing, supply agreement for Palbociclib Tablets for US market - Medical Dialogues","headline":"Zydus, Synthon enter into licensing, supply agreement for Palbociclib Tablets for US market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBkS3ZZY296SnhQcG5obGVxR05vSXZ0WFBPd281a0hBeDd4Vy1IY0ozQ2tMV3QyNHNlSEpoNmFKR3doZmM3cXZfUVJ2S0FQeEpRd2xpOFNFdmlzM04tbV9yaFlwdGl6VVBvU3FZN1930gFyQVVfeXFMTVhRak1UU3NyZmlMUTFhTjk0OE1fUlVOX3Z2STZXVzBFQ015ZWJZRTdybmt6TzhxSGJPaVZ6QU51NVk1amJERGJ3OExLcUFHVUMtS1loSU8zaGVmSWNNN250LWZzUFRTeUtYaWlLaGhSU0p3?oc=5","date":"2023-12-11","type":"deal","source":"koreabiomed.com","summary":"Daewoong strikes $92 million deal with Zydus to develop anticancer injection in US - koreabiomed.com","headline":"Daewoong strikes $92 million deal with Zydus to develop anticancer injection in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBBSmFxemJWYUJMRGVRWkZiXzNsdXUzUUZaUVhuYTl2UGFTLTJTamhpRU1MN19WZmpqU2FMVU0ybzJxcHRGZlBIMDRhUkRlZ3hxWGlwLUNaYy1MSHZFa3pmVWtCRkpnX184QTVNTVVn?oc=5","date":"2023-12-11","type":"pipeline","source":"KED Global","summary":"Daewoong exports $92.4 mn Depot injection tech to UAE - KED Global","headline":"Daewoong exports $92.4 mn Depot injection tech to UAE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFBNZTlkd1NjUnhwbDl3Y3plT3lPRVF0VElnTElIeXZGcmVyR245cFo2NkZQWDN5MFlJbTZ4RUZ4MHNRbEpyUXFHVnh1cDhPLWk4a1RwMVhn?oc=5","date":"2023-12-11","type":"deal","source":"The Korea Herald","summary":"Daewoong, Zydus ink $92m deal to develop generic drug in US - The Korea Herald","headline":"Daewoong, Zydus ink $92m deal to develop generic drug in US","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-12-11","type":"pipeline","source":"ET HealthWorld","summary":"Zydus Lifesciences inks licensing pact with Daewoong Pharmaceutical - ET HealthWorld","headline":"Zydus Lifesciences inks licensing pact with Daewoong Pharmaceutical","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-12-11","type":"pipeline","source":"Express Pharma","summary":"Zydus, Daewoong sign licensing pact to develop, market Leuprolide long-acting injectable in US - Express Pharma","headline":"Zydus, Daewoong sign licensing pact to develop, market Leuprolide long-acting injectable in US","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-07-18","type":"regulatory","source":"Indian Pharma Post","summary":"Zydus receives final approval from the USFDA for Efinaconazole Topical Solution - Indian Pharma Post","headline":"Zydus receives final approval from the USFDA for Efinaconazole Topical Solution","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2021-02-17","type":"patent","source":"Medical Dialogues","summary":"Zydus Cadila division settles patent litigation with Adamas Pharma over dyskinesia drug Gocovri - Medical Dialogues","headline":"Zydus Cadila division settles patent litigation with Adamas Pharma over dyskinesia drug Gocovri","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNZV9za25yc1RVR0UwZ2plclNaSlRZSkRGQktOVWJ5cWlPQUpiZEw5OGJBcm8wVXhEU1lJUnhGSXhWc0JoRmZzNEdEUmxJcVNpS3BRSTdINjB4RXEwZzdPdThJNzJrbTB5SHNZWGo4YzdpbzhKSnZsSDBWMWtVNlk5cmJB?oc=5","date":"2020-05-18","type":"pipeline","source":"JD Supra","summary":"Life Sciences Court Report & COVID-19 Impact on District Court Filings - JD Supra","headline":"Life Sciences Court Report & COVID-19 Impact on District Court Filings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE1MbHl3cWtMWGUzRXpkNHNYSW1QcnJoVElqcDZubF9PUUxMdEhHdHZSYi1DX29LRFFqSFdHQnpCcGlXbElRQkRGWVVESDh4Mm9zM3hEUVpmb2k3RjdmbGF6SWVlUXFDYllxbjVGeF9OT2tHY0RS?oc=5","date":"2016-07-29","type":"deal","source":"VCCircle","summary":"Cipla, Aurobindo Pharma to acquire drugs from Teva - VCCircle","headline":"Cipla, Aurobindo Pharma to acquire drugs from Teva","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOV25UQ3RQMnN4czZzMDZNaV9vRTZlcnBGX1ZIRGFRQmoxc3ctaHZMU0RJYkRxZ3d5T2dyMmJxSEVINmJHR1ZVUVEzcFZUVDVVOEhvSWYybmEwWmxrdW16VXhRRlRSc1d5OFF2V21FTmxwWXBpVXRpd25vSWZOcGh3OUg1VENGMEV4VDhRdVFNOXV3OTlYUmw5MmM1bFkxMnlTVFhCeWNFOW1CaUdEb01j?oc=5","date":"2016-07-27","type":"pipeline","source":"Bloomberg.com","summary":"Teva Wins U.S. Nod for Actavis After Divestiture of 79 Drugs - Bloomberg.com","headline":"Teva Wins U.S. Nod for Actavis After Divestiture of 79 Drugs","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}